Columbia International Affairs Online
CIAO DATE: 4/5/2008
Latin American Drugs II- Improving Policy and Reducing Harm
March 2008
Abstract
The policies of a decade or more to stop the flow of cocaine from the Andean source countries, Colombia, Peru and Bolivia, to the two largest consumer markets, the U.S. and Europe, have proved insufficient and ineffective. Cocaine availability and demand have essentially remained stable in the U.S. and have been increasing in Europe. Use in Latin American transit countries, in particular Argentina, Brazil and Chile, is on the rise. Flawed counter-drug polices also are causing considerable collateral damage in Latin America, undermining support for democratic governments in some countries, distorting governance and social priorities in others, causing all too frequent human rights violations and fuelling armed and/or social conflicts in Colombia, Bolivia and Peru. A comprehensive shared policy reassessment and a new consensus on the balance between approaches emphasising law enforcement and approaches emphasising alternative development and harm reduction are urgently required.
Counter-drug policies such as the U.S.-Colombian Plan Colombia and the European Union (EU) Drugs Strategy have not found an effective mix of supply and demand reduction measures. While on both sides of the Atlantic the lion’s share of counter-narcotics funds are invested in controlling the drug problem at home, neither the Washington law-enforcement orientation nor the Brussels public health orientation (which is not homogeneously shared across the EU) has significantly reduced cocaine use. Policy coordination between the U.S., Europe and Latin America is severly hampered by the marked differences on both how best to address the world’s overall drug problem and how to reduce cocaine supply, as well as by unrelated political disputes.
